Français
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
indole/cancer du sein
Le lien est enregistré dans le presse-papiers
9 résultats
Substituted-indole-compounds as estrogen receptor down-regulators
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
FIELD OF INVENTION
The present invention relates to a novel class of indole derivatives, particularly a compound represented by formula (I), a preparation method, a pharmaceutical composition and a use as estrogen receptor down-regulator in preparing a medicament for treating estrogen
2,3-dihydro-1H-indole compounds
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
The present invention relates to novel 2,3-dihydro-1H-indole compounds that inhibit the conversion of tryptophan to kynurenine, certain of which have been confirmed to bind to indoleamine 2,3-dioxygenase (IDO1). The present invention also relates to pharmaceutical compositions comprising these
Inhibitor of breast cancer resistance protein (BCRP)
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
BACKGROUND
Resistance to anticancer agents is a major cause of chemotherapeutic failure in cancer. (M. K. Rosenberg et al., Structure, 2010, 18, 482.) The 75 kDa human breast cancer resistance protein (BCRP) is a polytopic plasma membrane transport protein that has been detected in many
Breast cancer cell growth-inhibiting enzyme inhibitors, method for the production thereof, and use thereof
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
BACKGROUND OF THE INVENTION
According to epidemiological data, breast cancer is the most frequent form of cancer in women [1]. Particularly aggressive breast cancers are characterized by invasive and metastatic behavior [2]. The treatment of such aggressive breast cancers is extremely problematic
Indole derivatives
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
This application is a 371 of PCT/SP93/0056 filed Apr. 28, 1993.
TECHNICAL FIELD
The present invention relates to novel indole derivatives.
PRIOR ART
The indole derivatives of the invention are novel compounds not yet described in the literature.
DISCLOSURE OF INVENTION
It is an object of the
2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
The present invention relates to new 2-Phenyl-1-[4-(2-Aminoethoxy)-Benzyl]-Indole compounds which are useful as estrogenic agents, as well as pharmaceutical compositions and methods of treatment utilizing these compounds.
BACKGROUND OF THE INVENTION
The use of hormone replacement therapy for bone
Use of indole-derived compounds for the preparation of a medicament that can be used to treat diseases related to the splicing process
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
CROSS-REFERENCE TO RELATED APPLICATIONS
The present application is a national phase entry under 35 U.S.C. .sctn.371 of International Application No. PCT/FR2004/002261 filed Sep. 6, 2004, published in France, which claims priority from French Patent Application No. 0310460 filed Sep. 4, 2003 and
Substituted thiazolidinedione indazoles, indoles and benzotriazoles as estrogen-related receptor-.alpha. modulators
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
FIELD OF THE INVENTION
The present invention relates to certain novel compounds, methods for preparing compounds, compositions, intermediates and derivatives thereof and for treating conditions such as cancer, arthritis, inflammatory airway disease, and metabolic disorders. More particularly, the
17.beta.HSD type 5 inhibitor
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
TECHNICAL FIELD
The present invention relates to an indole compound having a pharmacological activity and a pharmaceutically acceptable salt thereof. The present invention also relates to a medicament or a pharmaceutical composition containing the indole compound or a pharmaceutically acceptable
La base de données d'herbes médicinales la plus complète soutenue par la science
- Fonctionne en 55 langues
- Cures à base de plantes soutenues par la science
- Reconnaissance des herbes par image
- Carte GPS interactive - étiquetez les herbes sur place (à venir)
- Lisez les publications scientifiques liées à votre recherche
- Rechercher les herbes médicinales par leurs effets
- Organisez vos intérêts et restez à jour avec les nouvelles recherches, essais cliniques et brevets
Tapez un symptôme ou une maladie et lisez des informations sur les herbes qui pourraient aider, tapez une herbe et voyez les maladies et symptômes contre lesquels elle est utilisée.
* Toutes les informations sont basées sur des recherches scientifiques publiées
